None
Quote | CSPC Pharmaceuticals Group Ltd. (OTCMKTS:CHJTF)
Last: | $0.75 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.75 |
High: | $0 |
Low: | $0 |
Volume: | 20,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | CSPC Pharmaceuticals Group Ltd. (OTCMKTS:CHJTF)
2023-03-29 07:00:00 ET Summary News of marketing approval for China’s first mRNA vaccine falls flat with investors, who worry the drug is being rushed to market before Phase 3 trials are complete. As the pandemic abates, the market for the vaccine is shrinking rapidly. ...
Summary Jiangsu Hengrui Pharma out-licensed US rights for a novel small-molecule EZH2 inhibitor in a $706 million agreement with Connecticut's Treeline Biosciences. A CSPC Pharma subsidiary out-licensed ex-China rights for a Nectin-4 antibody drug conjugate to Boston’s Corbus Pha...
Message Board Posts | CSPC Pharmaceuticals Group Ltd. (OTCMKTS:CHJTF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
CSPC Pharmaceuticals Group Ltd. Company Name:
CHJTF Stock Symbol:
OTCMKTS Market:
New York City, NY: April 06, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Cephradine Market in Global Industry: 2020 Research and New Innovations in Chemicals and Materials Sector. The prime objective of the report is to offer updates and ...